Literature DB >> 10819236

Free and protein bound leptin are distinct and independently controlled factors in energy regulation.

G Brabant1, R Horn, A von zur Mühlen, B Mayr, U Wurster, F Heidenreich, D Schnabel, A Grüters-Kieslich, T Zimmermann-Belsing, U Feldt-Rasmussen.   

Abstract

AIMS/HYPOTHESIS: Leptin exerts important regulating effects on energy homeostasis and could have a central role in our understanding of obesity, diabetes mellitus and the metabolic syndrome. Leptin circulates in a free and protein bound form. The aim of the present study was to test whether both fractions of the leptin system can be selectively regulated and thus serve independent physiological roles.
METHODS: Using specific radioimmunoassays we measured both leptin components in relation to BMI in healthy subjects before and after weight reduction and in hyperthyroid patients during correction of thyrotoxicosis. In the latter group body composition and resting energy expenditure was monitored. In addition, we measured serum and cerebrospinal fluid concentrations of free and bound leptin in patients with neurological disorders.
RESULTS: Under all conditions free leptin concentrations reflected body fat mass. Bound leptin concentrations decreased during weight reduction but also after treatment of hyperthyroidism despite an increase in fat mass. Direct measurement of resting energy expenditure and bound leptin in hyperthyroid patients and under thyrostatic treatment showed a significant positive correlation of both variables. In contrast to free leptin whose transport into the cerebrospinal fluid appears to be saturated at low physiological concentrations of serum free leptin, bound leptin concentrations in the cerebrospinal fluid increased in parallel to serum concentrations over the whole physiologically relevant range. CONCLUSION/
INTERPRETATION: Our data indicate a distinct role of free and bound leptin in the feedback regulating energy intake and expenditure and could have important implications for our understanding of the physiology and pathophysiology of leptin-dependent signalling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10819236     DOI: 10.1007/s001250051326

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  12 in total

Review 1.  Obesity and adipokines: effects on sympathetic overactivity.

Authors:  Michael M Smith; Christopher T Minson
Journal:  J Physiol       Date:  2012-02-20       Impact factor: 5.182

Review 2.  Influence of cortisol status on leptin secretion.

Authors:  A Leal-Cerro; A Soto; M A Martínez; C Dieguez; F F Casanueva
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

Review 3.  Plasma leptin and exercise: recent findings.

Authors:  M S Hickey; D J Calsbeek
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

4.  Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet.

Authors:  Greeshma K Shetty; Giuseppe Matarese; Faidon Magkos; Hyun-Seuk Moon; Xiaowen Liu; Aoife M Brennan; Geetha Mylvaganam; Despina Sykoutri; Alex M Depaoli; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2011-05-20       Impact factor: 6.664

5.  Relationship of leptin, resting metabolic rate, and body composition in premenopausal hispanic and non-Hispanic White women.

Authors:  Sarah E Deemer; George A King; Sandor Dorgo; Chantal A Vella; Joe W Tomaka; Dixie L Thompson
Journal:  Endocr Res       Date:  2010       Impact factor: 1.720

Review 6.  Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches.

Authors:  Alan R Schwartz; Susheel P Patil; Alison M Laffan; Vsevolod Polotsky; Hartmut Schneider; Philip L Smith
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

Review 7.  Nutritional regulation of leptin signaling.

Authors:  Catherine Ribiere; Charles Plut
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

8.  Reduced body weight and increased energy expenditure in transgenic mice over-expressing soluble leptin receptor.

Authors:  Phing-How Lou; Guoqing Yang; Lu Huang; Yunxia Cui; Tiffany Pourbahrami; George K Radda; Cai Li; Weiping Han
Journal:  PLoS One       Date:  2010-07-20       Impact factor: 3.240

9.  Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice.

Authors:  Makoto Ito; Sumiaki Fukuda; Shohei Sakata; Hisayo Morinaga; Takeshi Ohta
Journal:  J Diabetes Res       Date:  2014-05-29       Impact factor: 4.011

10.  Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.

Authors:  Qi Sun; Rob M van Dam; James B Meigs; Oscar H Franco; Christos S Mantzoros; Frank B Hu
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.